Lipid nanoparticulate drug delivery system for the treatment of hepatic fibrosis
<p>Background: Irreversible hepatic fibrosis, an excessive production and accumulation of extra cellular matrix by hepatic stellate cells in the liver, becomes a remarkable economic burden in global health care system.Low therapeutic efficacy and undesirable systemic effect of conventional the...
Saved in:
Main Authors: | Swarupananda Mukherjee (Author), Ayon Dutta (Author), Dipanjana Ash (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hepatitis Research - Peertechz Publications,
2021-01-28.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alcohol, hepatitis C screening and hepatic fibrosis in drug users
by: Di Nino F, et al.
Published: (2019) -
Nanoparticulate system for cancer therapy: An updated review
by: Dharmendra Kumar, et al.
Published: (2018) -
Lipid Delivery System and Functional Food
Published: (2023) -
Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis
Published: (2020) -
Smart Drug Delivery System
Published: (2016)